Loading...
XBiotech Inc (XBIT) is not a strong buy at the moment for a beginner investor with a long-term strategy. The stock lacks positive momentum, has bearish technical indicators, no significant trading trends, and no recent news or catalysts to drive upward movement. Additionally, the company's financial performance remains weak with no revenue and negative net income. Holding off on investment is recommended until stronger signals or catalysts emerge.
The technical indicators for XBIT are bearish. The MACD histogram is negative and contracting, RSI is neutral at 45.309, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The price is hovering near the pivot level of 2.382, with resistance at 2.45 and support at 2.313.

NULL identified. No recent news, no significant trading trends, and no influential figure activity.
Bearish technical indicators, lack of revenue growth, negative net income, and no significant trading trends from hedge funds or insiders.
In 2025/Q3, the company reported no revenue growth (0% YoY), negative net income of -$6,008,000 (though improved by 19.8% YoY), and an EPS of -0.2 (up 25% YoY). Gross margin remains at 0%. Overall, financials are weak with no clear growth trajectory.
No data available for analyst ratings or price target changes.
